796 related articles for article (PubMed ID: 23900345)
1. Gene therapy for cancer through adenovirus vector‑mediated expression of the Ad5 early region gene 1A based on loss of IGF2 imprinting.
Pan Y; He B; Lirong Z; Nie Z; Chen L; Gu L; Hoffman AR; Wang S; Hu J
Oncol Rep; 2013 Oct; 30(4):1814-22. PubMed ID: 23900345
[TBL] [Abstract][Full Text] [Related]
2. Gene therapy for colorectal cancer by an oncolytic adenovirus that targets loss of the insulin-like growth factor 2 imprinting system.
Nie ZL; Pan YQ; He BS; Gu L; Chen LP; Li R; Xu YQ; Gao TY; Song GQ; Hoffman AR; Wang SK; Hu JF
Mol Cancer; 2012 Nov; 11():86. PubMed ID: 23171475
[TBL] [Abstract][Full Text] [Related]
3. [Effect of recombinant adenovirus Ad-DT-A in targeted therapy for malignant cancer cell lines with loss of IGF2 imprinting].
Pan YQ; He BS; Zhu C; Qu LL; Xu XF; Wang SK
Zhonghua Zhong Liu Za Zhi; 2011 Nov; 33(11):816-21. PubMed ID: 22335945
[TBL] [Abstract][Full Text] [Related]
4. Gene therapy for human colorectal cancer cell lines with recombinant adenovirus 5 based on loss of the insulin-like growth factor 2 imprinting.
Sun H; Pan Y; He B; Deng Q; Li R; Xu Y; Chen J; Gao T; Ying H; Wang F; Liu X; Wang S
Int J Oncol; 2015 Apr; 46(4):1759-67. PubMed ID: 25625919
[TBL] [Abstract][Full Text] [Related]
5. Targeted tumor gene therapy based on loss of IGF2 imprinting.
Pan Y; He B; Li T; Zhu C; Zhang L; Wang B; Xu Y; Qu L; Hoffman AR; Wang S; Hu J
Cancer Biol Ther; 2010 Aug; 10(3):290-8. PubMed ID: 20592487
[TBL] [Abstract][Full Text] [Related]
6. Gene therapy for colorectal cancer by adenovirus-mediated siRNA targeting CD147 based on loss of the IGF2 imprinting system.
Pan Y; He B; Chen J; Sun H; Deng Q; Wang F; Ying H; Liu X; Lin K; Peng H; Xie H; Wang S
Int J Oncol; 2015 Nov; 47(5):1881-9. PubMed ID: 26397886
[TBL] [Abstract][Full Text] [Related]
7. Loss of insulin-like growth factor II imprinting is a hallmark associated with enhanced chemo/radiotherapy resistance in cancer stem cells.
Zhao X; Liu X; Wang G; Wen X; Zhang X; Hoffman AR; Li W; Hu JF; Cui J
Oncotarget; 2016 Aug; 7(32):51349-51364. PubMed ID: 27275535
[TBL] [Abstract][Full Text] [Related]
8. Loss of imprinting in colorectal cancer linked to hypomethylation of H19 and IGF2.
Cui H; Onyango P; Brandenburg S; Wu Y; Hsieh CL; Feinberg AP
Cancer Res; 2002 Nov; 62(22):6442-6. PubMed ID: 12438232
[TBL] [Abstract][Full Text] [Related]
9. Loss of imprinting of IGF2 correlates with hypomethylation of the H19 differentially methylated region in the tumor tissue of colorectal cancer patients.
Tian F; Tang Z; Song G; Pan Y; He B; Bao Q; Wang S
Mol Med Rep; 2012 Jun; 5(6):1536-40. PubMed ID: 22427002
[TBL] [Abstract][Full Text] [Related]
10. Tissue-specific relationship of S-adenosylhomocysteine with allele-specific H19/Igf2 methylation and imprinting in mice with hyperhomocysteinemia.
Glier MB; Ngai YF; Sulistyoningrum DC; Aleliunas RE; Bottiglieri T; Devlin AM
Epigenetics; 2013 Jan; 8(1):44-53. PubMed ID: 23221482
[TBL] [Abstract][Full Text] [Related]
11. Loss of Igf2 imprinting in monoclonal mouse hepatic tumor cells is not associated with abnormal methylation patterns for the H19, Igf2, and Kvlqt1 differentially methylated regions.
Ishizaki T; Yoshie M; Yaginuma Y; Tanaka T; Ogawa K
J Biol Chem; 2003 Feb; 278(8):6222-8. PubMed ID: 12475990
[TBL] [Abstract][Full Text] [Related]
12. H19 DMR methylation correlates to the progression of esophageal squamous cell carcinoma through IGF2 imprinting pathway.
Gao T; He B; Pan Y; Gu L; Chen L; Nie Z; Xu Y; Li R; Wang S
Clin Transl Oncol; 2014 Apr; 16(4):410-7. PubMed ID: 23943562
[TBL] [Abstract][Full Text] [Related]
13. Relationship of porcine IGF2 imprinting status to DNA methylation at the H19 DMD and the IGF2 DMRs 1 and 2.
Braunschweig MH; Owczarek-Lipska M; Stahlberger-Saitbekova N
BMC Genet; 2011 May; 12():47. PubMed ID: 21575277
[TBL] [Abstract][Full Text] [Related]
14. The long non-coding RNA 91H increases aggressive phenotype of breast cancer cells and up-regulates H19/IGF2 expression through epigenetic modifications.
Vennin C; Spruyt N; Robin YM; Chassat T; Le Bourhis X; Adriaenssens E
Cancer Lett; 2017 Jan; 385():198-206. PubMed ID: 27780718
[TBL] [Abstract][Full Text] [Related]
15. Imprinting of IGF2 and H19: lack of reciprocity in sporadic Beckwith-Wiedemann syndrome.
Joyce JA; Lam WK; Catchpoole DJ; Jenks P; Reik W; Maher ER; Schofield PN
Hum Mol Genet; 1997 Sep; 6(9):1543-8. PubMed ID: 9285792
[TBL] [Abstract][Full Text] [Related]
16. Combination of oncolytic adenovirus and endostatin inhibits human retinoblastoma in an in vivo mouse model.
Wang H; Wei F; Li H; Ji X; Li S; Chen X
Int J Mol Med; 2013 Feb; 31(2):377-85. PubMed ID: 23229955
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the Paternally-Imprinted DLK1-MEG3 and IGF2-H19 Tandem Gene Loci in NT2 Embryonal Carcinoma Cells Identifies DLK1 as a Potential Therapeutic Target.
Sellers ZP; Schneider G; Maj M; Ratajczak MZ
Stem Cell Rev Rep; 2018 Dec; 14(6):823-836. PubMed ID: 29980981
[TBL] [Abstract][Full Text] [Related]
18. Quantitative allele-specific expression and DNA methylation analysis of H19, IGF2 and IGF2R in the human placenta across gestation reveals H19 imprinting plasticity.
Buckberry S; Bianco-Miotto T; Hiendleder S; Roberts CT
PLoS One; 2012; 7(12):e51210. PubMed ID: 23227253
[TBL] [Abstract][Full Text] [Related]
19. Loss of imprinting and marked gene elevation are 2 forms of aberrant IGF2 expression in colorectal cancer.
Cheng YW; Idrees K; Shattock R; Khan SA; Zeng Z; Brennan CW; Paty P; Barany F
Int J Cancer; 2010 Aug; 127(3):568-77. PubMed ID: 19957330
[TBL] [Abstract][Full Text] [Related]
20. Loss of IGF2 imprinting is associated with abrogation of long-range intrachromosomal interactions in human cancer cells.
Vu TH; Nguyen AH; Hoffman AR
Hum Mol Genet; 2010 Mar; 19(5):901-19. PubMed ID: 20015958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
